(Q39990751)

English

Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Jun Ren

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jun Jia

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hongmei Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Liwang Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Bo Ma

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hanfang Jiang

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lijun Di

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Guohong Song

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jing Yu

9

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

16 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1420-1426

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Nonresectional therapies for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Liver transplantation in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Anti-idiotype vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Dendritic cells in vaccination therapies of human malignant disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Immunodominance and tumor escape

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00820.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2008.00820.X

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39990751&oldid=1882078808"